Table 3. Venous blood gas, hormonal and biochemical parameters in HAPE susceptible (HAPE-S) and HAPE resistant (HAPE-R) subjects.
| Group 1 (HAPE-S) (n = 11) | Group 2 (HAPE-R) | |
|---|---|---|
| T3 (pg/dl) | 1.3 ± 0.3 | 1.0 ± 0.3* (n = 7) |
| T4 (pg/dl) | 112.7 ± 37.3 | 126.4 ± 47.1 (n = 7) |
| TSH (μIU/ml) | 2.0 ± 0.9 | 2.9 ± 1.8 (n = 7) |
| pH | 7.3 ± 0.04 | 7.29 ± 0.03 (n = 11) |
| Pvo2 (mm Hg) | 24.9 ± 5.4 | 16.0 ± 4.2* (n = 11) |
| Svo2% | 36.1 ± 13.4 | 19 ± 7.8* (n = 11) |
| P50 (mm Hg) | 26.3 ± 1.6 | 24.4 ± 3.2* (n = 11) |
| ANP (pg/dl) | 17.3 ± 9 | 8.4 ± 7.7* (n = 9) |
| HIF1α (pg/ml) | 320.3 ± 267.5 | 58.7 ± 33.9* (n = 5) |
| 2–3DPG (nmol/ml) | 5.3 ± 1.4 | 5.2 ± 2.3 (n = 7) |
Values are presented as Mean ± SD. T3: Triiodothyronine; T4: Thyroxine; TSH: Thyroid stimulating hormone; Pvo2: partial pressure of venous oxygen; Svo2: % venous saturation; ANP: atrial natriuretic peptide; HIF 1α: hypoxia inducible factor 1α; 2–3 DPG: Diphospho glyceric acid.
*p < 0.05 (HAPE-S versus HAPE-R).